JP Morgan Maintains Underweight on Cabot, Raises Price Target to $78
JP Morgan analyst Jeffrey Zekauskas maintains Cabot (NYSE:CBT) with a Underweight and raises the price target from $70 to $78.
Read original at benzingaStocks · News reference
8-K filing — CABOT CORP (CBT)
Filed: 2026-08-21 AccNo: 0001193125-26-361109 Size: 280 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 21, 2026, 8:12 PM
- Checked
- Aug 21, 2026, 8:12 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Neutral on Cabot, Lowers Price Target to $92
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $97 to $92.
Read original at benzingaCBT stock has given up its prior gain. Cabot shares were trading higher after the company reported better-than-expected Q3 financial results.
Read original at benzinga